Has Ivan Fernandez Madrid, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,407 in general payments to Ivan Fernandez Madrid, MD across 94 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ivan Fernandez Madrid, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ivan Fernandez Madrid, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ivan Fernandez Madrid, MD

Orthopaedic Surgery · New York, NYNPI 1912940107

Payments from drug & device makers

$14,407in general payments, 2019–2025

Across 94 payments — averaging $153.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$8K
Arthrex$2K
Zimmer Biomet$1K
Orthosensor Inc.$1K
Stryker$448
Amgen$435
plus $1K from 8 others

What the payments were for

Travel & lodging$7,06953%
Food & beverage$6,29647%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	41	$8,180
Arthrex	16	$1,794
Zimmer Biomet	14	$1,420
Orthosensor Inc.	4	$1,043
Stryker	3	$448
Amgen	6	$435
Suvon Surgical LLC	2	$318
Davol Inc.	1	$244
Intellijoint Surgical Inc.	1	$176
Miach Orthopaedics, Inc.	1	$161
Lifenet Health	1	$103
Brainlab, Inc.	2	$55
Ferring Pharmaceuticals Inc.	1	$19
KCI USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,407 in reported general payments places this provider in the 70th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$230,323

Medicare patients

437

Services billed

7,492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	23	$77
Meloxicam	14	$61
Tramadol Hcl	15	$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

Anthony RomeoNew York$27M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$14.1M
William RicciNew York$11.6M
Steven HaasNew York$11.5M
Giles ScuderiNew York$10.9M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →